U.K.'s NICE recommends Sirtex's microsphere for liver cancer

By AuntMinnieEurope.com staff writers

February 26, 2021 -- The U.K. National Institute for Health and Care Excellence (NICE) gave radiation oncology firm Sirtex Medical positive guidance on the use of its selection internal radiation therapy (SIRT) with SIR-Spheres yttrium-90 microspheres for the treatment of adults with unresectable advanced hepatocellular carcinoma (HCC).

The NICE recommends SIR-Spheres in England and Wales as a fully funded and reimbursed option for adult patients with HCC if it's used in people with Child-Pugh grade A liver impairment when conventional transarterial therapies are inappropriate.

Also, the company must provide SIR-Spheres according to the commercial arrangement, the NICE said.


Copyright © 2021 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: